Clinical Trials Browser

Phase 1 × bemarituzumab × Gastrointestinal × Clear all

NCT02318329 2024-06-04

Open-Label, Dose-Finding Study Evaluating Safety and PK of FPA144 in Patients With Advanced Solid Tumors

Phase 1 Completed

79 enrolled 21 charts

GastrointestinalGenitourinary

Urinary Bladder Neoplasms, Esophageal Neoplasms, Stomach Neoplasms

NCT03343301 2024-02-28

FIGHT

Phase 1 Completed

12 enrolled 17 charts

Gastrointestinal

Gastrointestinal Neoplasms, Stomach Neoplasms

NCT05913115 2023-06-22

A Study Evaluating Safety and Pharmacokinetics of FPA144 in Japanese Patients With Advanced Gastric or Gastroesophageal Cancer

Phase 1 Completed

Gastrointestinal

Gastric or Gastroesophageal Cancer